LEXX

LEXX

USD

Lexaria Bioscience Corp. Common Stock

$1.110+0.120 (12.121%)

Real-time Price

Healthcare
Biotechnology
Canada

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$0.990

High

$1.137

Low

$0.990

Volume

0.17M

Company Fundamentals

Market Cap

24.7M

Industry

Biotechnology

Country

Canada

Trading Stats

Avg Volume

0.57M

Exchange

NCM

Currency

USD

52-Week Range

Low $0.775Current $1.110High $2.85

Related News

AccessWire

Lexaria Bioscience Corp. Provides Strategic Update

Strategic Business Development Advisory Firm Engaged To Support New Business Development ActivitiesLexaria Awarded 4 New Patents KELOWNA, BC / ACCESS Newswire / October 9, 2025 / Lexaria Bioscience Corp.

View more
Lexaria Bioscience Corp. Provides Strategic Update
AccessWire

Lexaria Bioscience Corp. Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

KELOWNA, BC / ACCESS Newswire / September 29, 2025 / Lexaria Bioscience Corp.

View more
Lexaria Bioscience Corp. Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
AccessWire

Lexaria Bioscience Corp. Announces $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

KELOWNA, BC / ACCESS Newswire / September 26, 2025 / Lexaria Bioscience Corp. ) , a global innovator in drug delivery platforms, today announced that it

View more
Lexaria Bioscience Corp. Announces $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
AccessWire

Lexaria's Technology Supports Higher Levels of the GLP-1 Drug Semaglutide in Brain

Enhanced Brain Biodistribution of GLP-1 Drugs May Be Related to Improvements in Safety and Efficacy KELOWNA, BC / ACCESS Newswire / September 19, 2025 / Lexaria Bioscience Corp. (the

View more
Lexaria's Technology Supports Higher Levels of the GLP-1 Drug Semaglutide in Brain